Cecors Inc Stock Key Fundamental Indicators
| CEOS Stock | USD 0 0.0002 8.00% |
CeCors Inc technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the firm's future prices.
CeCors' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CeCors' valuation are provided below:CeCors Inc does not now have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. CeCors |
CeCors 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CeCors' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CeCors.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in CeCors on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding CeCors Inc or generate 0.0% return on investment in CeCors over 90 days. Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingr... More
CeCors Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CeCors' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CeCors Inc upside and downside potential and time the market with a certain degree of confidence.
CeCors Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CeCors' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CeCors' standard deviation. In reality, there are many statistical measures that can use CeCors historical prices to predict the future CeCors' volatility.CeCors Inc Backtested Returns
CeCors Inc retains Efficiency (Sharpe Ratio) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. CeCors exposes five different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CeCors' day median price of 0.0023, and Price Action Indicator of (0.0001) to double-check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and CeCors are completely uncorrelated. At this point, CeCors Inc has a negative expected return of -0.0949%. Please make sure to confirm CeCors' day median price , to decide if CeCors Inc performance from the past will be repeated at future time.
Auto-correlation | 0.25 |
Poor predictability
CeCors Inc has poor predictability. Overlapping area represents the amount of predictability between CeCors time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CeCors Inc price movement. The serial correlation of 0.25 indicates that over 25.0% of current CeCors price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.25 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, CeCors Inc has a Price To Earning of -0.05 times. This is 100.19% lower than that of the Healthcare sector and 100.14% lower than that of the Medical Instruments & Supplies industry. The price to earning for all United States stocks is 100.17% higher than that of the company.
CeCors Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CeCors's current stock value. Our valuation model uses many indicators to compare CeCors value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CeCors competition to find correlations between indicators driving CeCors's intrinsic value. More Info.CeCors Inc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CeCors' earnings, one of the primary drivers of an investment's value.CeCors Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CeCors' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CeCors could also be used in its relative valuation, which is a method of valuing CeCors by comparing valuation metrics of similar companies.CeCors is currently under evaluation in price to earning category among its peers.
CeCors Fundamentals
| Return On Equity | -7.26 | |||
| Return On Asset | -1.8 | |||
| Current Valuation | 87.7 K | |||
| Price To Earning | (0.05) X | |||
| EBITDA | (3.72 M) | |||
| Net Income | (9.3 M) | |||
| Cash And Equivalents | 57.42 K | |||
| Total Debt | 956.88 K | |||
| Current Ratio | 0.33 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (6.88 M) | |||
| Earnings Per Share | (0.41) X | |||
| Beta | 0.11 | |||
| Market Capitalization | 14.15 K | |||
| Total Asset | 2.26 M | |||
| Retained Earnings | (33.91 M) | |||
| Working Capital | (229 K) | |||
| Current Asset | 114 K | |||
| Current Liabilities | 343 K | |||
| Z Score | -24.3 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 2.26 M |
About CeCors Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CeCors Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CeCors using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CeCors Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada. CECORS INC operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 6 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CeCors Pink Sheet Analysis
When running CeCors' price analysis, check to measure CeCors' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CeCors is operating at the current time. Most of CeCors' value examination focuses on studying past and present price action to predict the probability of CeCors' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CeCors' price. Additionally, you may evaluate how the addition of CeCors to your portfolios can decrease your overall portfolio volatility.